Your World, Fully Explored.
Published loading...Updated

T-cells with a license to kill viruses

Summary by Medical Xpress
A research group led by Kyoto University has produced the world's first pluripotent stem cell-derived killer T-cell drug to treat COVID-19. The University has filed a patent application ahead of full-scale drug development.

Bias Distribution

  • 100% of the sources are Center
100% Center
Factuality

To view factuality data please Upgrade to Premium

Ownership

To view ownership data please Upgrade to Vantage

Medical Xpress broke the news in on Friday, August 2, 2024.
Sources are mostly out of (0)